No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Transcatheter Cardiovascular Therapeutic (TCT) market is a subset of the larger cardiovascular device market. It includes a range of products used to treat cardiovascular diseases, such as coronary artery disease, valvular heart disease, and structural heart disease. These products include transcatheter aortic valve replacement (TAVR) devices, transcatheter mitral valve replacement (TMVR) devices, transcatheter pulmonary valve replacement (TPVR) devices, and transcatheter left atrial appendage closure (LAAC) devices. These devices are used to treat cardiovascular diseases without the need for open-heart surgery.
The TCT market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate in the coming years.
Some of the major companies in the TCT market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and Terumo Corporation. Show Less Read more
